The University of Massachusetts Amherst is a public research university in Amherst, Massachusetts and the sole public land-grant university in Commonwealth of Massachusetts.

During the past decade, University of Massachusetts Amherst conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Massachusetts Amherst" #1 sponsor was "University of Massachusetts, Amherst" with 22 trials, followed by "Sanofi" with 2 trials sponsored, "Hartford Hospital" with 1 trials sponsored, "Temple University" with 1 trials sponsored and "Washington University School of Medicine" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Massachusetts Amherst" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "ALS Association" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "University of Massachusetts Amherst" are "Sleep" (5 trials), "Arthritis" (2 trials), "Fatigue" (2 trials), "Adolescent Development" (1 trials) and "Age" (1 trials). Many other conditions were trialed in "University of Massachusetts Amherst" in a lesser frequency.

Most popular intervention types in "University of Massachusetts Amherst" are "Behavioral" (16 trials), "Device" (6 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tolebrutinib" (2 trials), "6-week basic dog obedience training course" (1 trials), "Atorvastatin" (1 trials) and "Bose Hearphones" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Massachusetts Amherst" are 24 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Massachusetts Amherst". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in University of Massachusetts Amherst, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Massachusetts Amherst, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 22 trials that are defined as “Not Applicable".